![Matthew Fust](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Fust
Directeur/Membre du Conseil chez
ATARA BIOTHERAPEUTICS, INC.
Fortune : 1 M $ au 31/08/2026
Profil
Mr. Matthew K.
Fust is an Independent Director at Electra Therapeutics, Inc., an Independent Director at Neumora Therapeutics, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., an Independent Director at Atara Biotherapeutics, Inc. and an Independent Director at Ultragenyx Pharmaceutical, Inc. He is on the Board of Directors at Electra Therapeutics, Inc., Arsenal Biosciences, Inc., Neumora Therapeutics, Inc., Crinetics Pharmaceuticals, Inc., Atara Biotherapeutics, Inc. and Ultragenyx Pharmaceutical, Inc. Mr. Fust was previously employed as an Independent Director by Dermira, Inc., an Independent Director by MacroGenics, Inc., an Executive Vice President-Finance by Onyx Pharmaceuticals, Inc., an Independent Director by Sunesis Pharmaceuticals, Inc., a Chief Financial Officer & Executive Vice President by Jazz Pharmaceuticals, Inc., a Chief Financial Officer by Perlegen Sciences, Inc., a Chief Financial Officer & Senior Vice President by ALZA Corp., and a Manager-Healthcare Strategy Practice by Anderson Consulting Team.
He also served on the board at BlackThorn Therapeutics, Inc. He received his undergraduate degree from the University of Minnesota and an MBA from Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2026 | 33 696 ( 0,03 % ) | 849 476 $ | 31/08/2026 | |
| 09/06/2026 | 30 188 ( 0,3 % ) | 268 673 $ | 31/08/2026 | |
| 27/05/2026 | 20 100 ( 0,01 % ) | 26 733 $ | 31/08/2026 |
Postes actifs de Matthew Fust
| Sociétés | Poste | Début |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 01/01/2014 |
| ATARA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2014 |
| NEUMORA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2020 |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Directeur/Membre du Conseil | 08/03/2021 |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Directeur/Membre du Conseil | 01/11/2023 |
Anciens postes connus de Matthew Fust
| Sociétés | Poste | Fin |
|---|---|---|
| CRINETICS PHARMACEUTICALS | Directeur/Membre du Conseil | 01/09/2026 |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Directeur/Membre du Conseil | 01/06/2020 |
| MACROGENICS, INC. | Directeur/Membre du Conseil | 14/05/2020 |
| DERMIRA, INC. | Directeur/Membre du Conseil | 20/02/2020 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Matthew Fust
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Discovers and develops drugs | Retail Trade |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Anderson Consulting Team
 Anderson Consulting Team Movies/EntertainmentConsumer Services Provides event planning services | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Health Technology |
